Health Economics

Translating evidence
into strategic impact

Delivering compelling economic and patient-centric evidence
to maximise market access, pricing and commercial success.

Decoding health economic data for impact

Becoya Health Economics transforms complex clinical and economic data into localised evidence and health economic models, enabling precise pricing and submission strategies. We anticipate your stakeholder needs and optimise your HTA outcomes & therapy adoption across regional markets.

Quantifying value across clinical landscapes

Real-World Evidence Generation & Outcomes Research

We generate actionable evidence through observational studies, registries and PRO/ClinRO frameworks to support clinical and commercial decisions.

Economic Modelling & Health Technology Assessments

We develop localised health-economic models tailored to the needs of payers across national and local levels.

Evidence Synthesis & Meta-Analysis

We combine literature, network meta-analysis and indirect comparisons to generate quantitative insights supporting launch and commercial strategy.

Precision born from presence

Multi-disciplinary health economists and scientific experts

Tools for instant, customisable economic modelling

HTA-ready evidence packages with submission support

Evidence generation in markets with limited data availability

Interactive, client-tailored value communication frameworks

Lessons from
complex launches

Using local hospital data to prevent a mandatory price cut for a cardiovascular drug

Cost-minimization analysis to optimize net price strategy for an oncology biologic in KSA

Developing a budget impact model to support the listing of a novel GLP-1 in the UAE

Tools tuned to regional nuance

Proprietary tools and analytics that simplify complex regional planning, from tracking prices and modelling budgets to identifying the right partners and mapping influencers.

Learn more

Evidence-driven decisions across healthcare landscape

Empowering life sciences organisations to generate, interpret, and apply health economic evidence that drives access, adoption, and sustainable growth across regional markets.

Evidence-driven decisions across healthcare landscape

Empowering life sciences organisations to generate, interpret, and apply health economic evidence that drives access, adoption, and sustainable growth across regional markets.

Pharmaceutical & biotech companies

Medical device manufacturers

Diagnostics manufacturers

Insights designed
for execution